Koers MERCK Kommanditgesellschaft auf Aktien Other OTC
Aandelen
MKKGY
US5893392093
Farmaceutische producten
Omzet 2024 * | 21,32 mld. 22,78 mld. | Omzet 2025 * | 22,64 mld. 24,18 mld. | Marktkapitalisatie | 68,48 mld. 73,14 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 2,99 mld. 3,2 mld. | Nettowinst (verlies) 2025 * | 3,52 mld. 3,76 mld. | EV/omzet 2024 * | 3,51 x |
Nettoschuld 2024 * | 6,38 mld. 6,82 mld. | Nettoschuld 2025 * | 4,56 mld. 4,87 mld. | EV/omzet 2025 * | 3,23 x |
K/w-verhouding 2024 * |
22,9
x | K/w-verhouding 2025 * |
19,3
x | Werknemers | - |
Dividendrendement 2024 * |
1,48% | Dividendrendement 2025 * |
1,62% | Vrij verhandelbaar | 29,71% |
Recentste transcriptie over MERCK Kommanditgesellschaft auf Aktien
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 13-07-20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01-08-14 |
Director of Finance/CFO | 54 | 26-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01-05-12 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01-01-91 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,03% | 9,11 mld. | |
-23,31% | 4,44 mld. | |
+15,70% | 4,24 mld. | |
+32,83% | 4,03 mld. | |
+9,37% | 2,14 mld. | |
+9,30% | 1,94 mld. | |
-33,37% | 1,9 mld. | |
-0,50% | 1,64 mld. | |
-46,20% | 1,63 mld. |